![James C. Lancaster](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James C. Lancaster
Nessuna posizione attualmente
Profilo
James C.
Lancaster Jr. has been Vice President of Commercial Operations for OREXIGEN Therapeutics, Inc. since August 2006.
Previously, he was a Marketing Consultant for Alkermes, Inc., G & S Research, Inc., Corcept Therapeutics, Inc., Neuronetics, Inc. and Eli Lilly and Company from March 2004 to August 2006.
Mr. Lancaster received a BS degree in Pharmacy from the University of Tennessee.
Precedenti posizioni note di James C. Lancaster
Società | Posizione | Fine |
---|---|---|
OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 10/03/2008 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/02/2003 |
Formazione di James C. Lancaster
University of Tennessee | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Aziende private | 1 |
---|---|
Orexigen Therapeutics, Inc.
![]() Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- James C. Lancaster